| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0001516 | Prostaglandin biosynthetic process | Increases phenotype | PMID:30102949 |
| GO:0001659 | Temperature homeostasis | Affects phenotype | PMID:30009846 |
| GO:0002539 | Prostaglandin production involved in inflammatory response | Increases phenotype | PMID:29793499 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:29775722; PMID:30102949; PMID:32061760 |
| GO:0004784 | Superoxide dismutase activity | Affects phenotype | PMID:25149237; PMID:29775722; PMID:30102949; PMID:32408700 |
| GO:0005248 | Voltage-gated sodium channel activity | Affects phenotype | PMID:25521199 |
| GO:0006693 | Prostaglandin metabolic process | Affects phenotype | PMID:32061760 |
| GO:0006694 | Steroid biosynthetic process | Affects phenotype | PMID:34896276 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:32408700 |
| GO:0006750 | Glutathione biosynthetic process | Affects phenotype | PMID:25149237; PMID:29775722; PMID:30102949 |
| GO:0006809 | Nitric oxide biosynthetic process | Increases phenotype | PMID:29775722; PMID:30102949 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:27916261; PMID:31734314 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:32408700 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:32408700 |
| GO:0007625 | Grooming behavior | Decreases phenotype | PMID:29775722 |
| GO:0008219 | Cell death | Decreases phenotype | PMID:30102949 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:24938463; PMID:28251819 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:29149346; PMID:29793499 |
| GO:0008344 | Adult locomotory behavior | Decreases phenotype | PMID:30102949 |
| GO:0010729 | Positive regulation of hydrogen peroxide biosynthetic process | Increases phenotype | PMID:29793499 |
| GO:0010917 | Negative regulation of mitochondrial membrane potential | Increases phenotype | PMID:38040083 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:25149237; PMID:29775722; PMID:30102949; PMID:32061760; PMID:32408700 |
| GO:0016887 | Atp hydrolysis activity | Decreases phenotype | PMID:29775722 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:29775722; PMID:30102949; PMID:32408700 |
| GO:0019432 | Triglyceride biosynthetic process | Increases phenotype | PMID:29554630 |
| GO:0030534 | Adult behavior | Affects phenotype | PMID:30009846 |
| GO:0031959 | Mineralocorticoid receptor signaling pathway | Increases phenotype | PMID:29149346 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:29793499 |
| GO:0035148 | Tube formation | Decreases phenotype | PMID:31734314 |
| GO:0036126 | Sperm flagellum | Affects phenotype | PMID:32408700 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:31734314; PMID:32061760 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:29793499 |
| GO:0046058 | Camp metabolic process | Affects phenotype | PMID:34896276 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:32061760 |
| GO:0050665 | Hydrogen peroxide biosynthetic process | Affects phenotype | PMID:32061760 |
| GO:0051091 | Positive regulation of dna-binding transcription factor activity | Increases phenotype | PMID:28973306 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:32408700 |
| GO:0061827 | Sperm head | Affects phenotype | PMID:32408700 |
| GO:0072520 | Seminiferous tubule development | Affects phenotype | PMID:32408700 |
| GO:0072593 | Reactive oxygen species metabolic process | Affects phenotype | PMID:32061760; PMID:32408700 |
| GO:0097225 | Sperm midpiece | Affects phenotype | PMID:32408700 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:32408700 |
| GO:1901216 | Positive regulation of neuron death | Increases phenotype | PMID:29793499 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:29793499 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Increases phenotype | PMID:26071804 |
| GO:1903283 | Negative regulation of glutathione peroxidase activity | Increases phenotype | PMID:29793499 |
| GO:1903407 | Negative regulation of p-type sodium:potassium-exchanging transporter activity | Increases phenotype | PMID:30978409 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:25149237; PMID:27916261; PMID:29775722 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:26071804; PMID:29793499 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.